Genetics of Congenital Obstructive Uropathy
先天性梗阻性尿病的遗传学
基本信息
- 批准号:9324211
- 负责人:
- 金额:$ 51.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-12 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelBiological AssayCandidate Disease GeneCategoriesCell Culture TechniquesChildhoodCodeCommunitiesComputer SimulationDNA ResequencingDataDevelopmentDiagnosticDiseaseEmbryonic DevelopmentFamilyFibroblast Growth FactorGenesGeneticGenetic CrossesGenetic HeterogeneityGenetic ScreeningGenetic studyGoalsHumanHydronephrosisKidneyKidney FailureKnock-outKnockout MiceModelingMolecular ProfilingMusMutationPathogenesisPathogenicityPatientsPenetrancePhenotypePregnancyProteinsResearchSignal TransductionSusceptibility GeneTestingTherapeuticTransgenic OrganismsUltrasonographyUrinary tractVariantZebrafishbasecohortcongenital anomalycostdata sharingdisease-causing mutationexomeexome sequencinggenetic pedigreeimaging studyinnovationinsightmalformationmouse modelnephrogenesisnext generation sequencingnovelnovel diagnosticsnovel therapeutic interventionoverexpressionprenatalpublic health relevancetraiturinary tract obstruction
项目摘要
DESCRIPTION (provided by applicant): Congenital Anomalies of the Kidney and the Urinary Tract (CAKUT) account for 40-50% of pediatric end-stage kidney failure worldwide. Among CAKUT categories, congenital obstructive uropathy represents a common and severe form of malformation. Congenital hydronephrosis is the most frequent anomaly of the urinary tract detected by prenatal ultrasound, occurring in up to 2% of normal pregnancies. Congenital obstructive uropathy can occur as familial or sporadic disease with highly variable phenotypic expression. Due to paucity of fundamental insight about primary pathogenesis, diagnostic and therapeutic options are severely limited. We recently implemented whole exome sequencing combined to functional modeling in zebrafish to identify dominant mutations in DSTYK in up to 2.3% of patients with congenital obstructive uropathy and associated urinary tract malformations (Sanna-Cherchi et al, New Engl J Med 2013). The protein encoded by DSTYK acts as a positive regulator of fibroblast growth factor (FGF) signaling during nephrogenesis. This study illustrates the power of combining whole exome sequencing with functional modeling in animal models to identify novel disease causing mutations in traits characterized by high genetic heterogeneity, incomplete penetrance, variable phenotypic expression, and small/medium pedigree size. Here we propose to characterize the function of DSTYK during embryonic development and nephrogenesis in cell cultures and in mouse models harboring Dstyk mutations, to extend our gene identification effort to 50 additional families with autosomal dominant congenital obstructive uropathy and to perform functional modeling in zebrafish to identify novel susceptibility genes. This study will provide insight into the pathogenesis of congenital obstructive uropathy in humans and animal models and will help develop new diagnostic and therapeutic strategies.
描述(由申请人提供):先天性肾脏和尿路异常(先天性肾脏和尿路异常)占全球儿童终末期肾衰竭的40-50%。在ckut类别中,先天性梗阻性尿路病变是一种常见且严重的畸形。先天性肾积水是产前超声检测到的最常见的尿路异常,在正常妊娠中发生率高达2%。先天性梗阻性尿路病变可以发生为家族性或散发性疾病,具有高度可变的表型表达。由于缺乏对主要发病机制的基本认识,诊断和治疗选择受到严重限制。我们最近在斑马鱼中实施了全外显子组测序结合功能建模,以确定高达2.3%的先天性阻塞性尿路病和相关尿路畸形患者的DSTYK显性突变(sana - cherchi等,New Engl J Med 2013)。DSTYK编码的蛋白在肾形成过程中作为成纤维细胞生长因子(FGF)信号的正调节因子。该研究表明,将全外显子组测序与动物模型的功能建模相结合,可以识别具有高遗传异质性、不完全外显子、可变表型表达和中小型家系大小的特征的新型疾病突变。在这里,我们建议在细胞培养和携带DSTYK突变的小鼠模型中表征DSTYK在胚胎发育和肾形成过程中的功能,将我们的基因鉴定工作扩展到50个常染色体显性先天性梗阻性尿病家族,并在斑马鱼中进行功能建模以鉴定新的易感基因。本研究将为人类和动物模型中先天性梗阻性尿路病变的发病机制提供深入的见解,并将有助于开发新的诊断和治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Simone Sanna-Cherchi其他文献
Simone Sanna-Cherchi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Simone Sanna-Cherchi', 18)}}的其他基金
Genomics of mammalian posterior urethral valves
哺乳动物后尿道瓣膜的基因组学
- 批准号:
10247469 - 财政年份:2017
- 资助金额:
$ 51.35万 - 项目类别:
Genomics of mammalian posterior urethral valves
哺乳动物后尿道瓣膜的基因组学
- 批准号:
9427411 - 财政年份:2017
- 资助金额:
$ 51.35万 - 项目类别:
Genetic diagnosis of kidney and urinary tract malformations via copy number varia
通过拷贝数变异对肾脏和尿路畸形进行基因诊断
- 批准号:
8638603 - 财政年份:2013
- 资助金额:
$ 51.35万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 51.35万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 51.35万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 51.35万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 51.35万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 51.35万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 51.35万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 51.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 51.35万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 51.35万 - 项目类别:
Postdoctoral Fellowships